Deprescribing Potentially Inappropriate Medications in the Emergency Department for Persons Living with Dementia
Launched by NATIONAL INSTITUTE ON AGING (NIA) · Feb 20, 2024
Trial Information
Current as of October 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to safely reduce the use of certain medications that may not be suitable for people with dementia when they visit the emergency department (ED). The goal is to ensure that medications are reviewed carefully and that communication happens between the pharmacists in the ED and the doctors who will care for these patients afterward. Researchers want to see if they can collect important information about how well this approach works over time, particularly in reducing unnecessary medications and preventing future hospital visits.
To be eligible for this trial, participants need to be at least 18 years old and have a diagnosis of dementia or mild cognitive impairment. They should also be living in the community, be able to discuss their medications with a pharmacist, and have received care at a Northwestern Medicine location before. If you or a loved one decides to participate, you can expect to work with a pharmacist in the ED who will help review medications and communicate with your regular doctors. This trial is currently recruiting participants, and it’s important to note that individuals with critical emergency conditions or those living in care facilities are not eligible.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Community dwelling
- • 18 years of age or older
- • History of dementia or mild cognitive impairment in the problem list in the NM EHR. A history of mild cognitive impairment will be identified using the ICD-10 code G31.84 (mild cognitive impairment) or ICD-10 codes suggestive of ADRD as described in the Bynum-standard algorithm: F01.50-F01.51 (vascular dementia), F02.80-F02.81 (dementia), F03.90-F03.91 (unspecified dementia), F04 (amnestic disorder), G30.0/30.1/30.8/G30.9 (Alzheimer's disease), G31.01 (Pick's disease), G31.09 (frontotemporal dementia), G31.83 (dementia with Lewy bodies), G31.1 (senile degeneration), G31.2 (degeneration of nervous system), R41.81 (age-related cognitive decline).
- • Able to participate in medication reconciliation as determined by the pharmacist per usual care OR a care partner with knowledge of the patient's current medications is present in the ED or is available by phone.
- • Has had prior outpatient care performed at Northwestern Medicine location(s)
- • Arrives to the emergency department between 7am and 7pm, Monday-Friday
- Exclusion Criteria:
- • Emergency Severity Index (ESI) of 1 (critical)
- • ICU consult placed in the ED
- • Reside in nursing facility or assisted living facility
About National Institute On Aging (Nia)
The National Institute on Aging (NIA) is a prominent research organization within the National Institutes of Health (NIH) dedicated to advancing our understanding of aging and age-related diseases. Through a robust portfolio of clinical trials, the NIA focuses on innovative research that aims to enhance the health and well-being of older adults. By fostering collaboration among scientists, healthcare professionals, and communities, the NIA seeks to translate research findings into practical solutions that improve the quality of life for aging populations. Their commitment to rigorous scientific inquiry and public health underscores their role as a leader in geriatric research and the pursuit of effective interventions for age-associated conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Lake Forest, Illinois, United States
Palos Heights, Illinois, United States
Patients applied
Trial Officials
Scott Dresden, Dr.
Principal Investigator
Northwestern University- Department of Emergency Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported